Factors Associated with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis

被引:0
作者
Sepandi, Mojtaba [1 ,2 ]
Taghdir, Maryam [1 ]
Alimohamadi, Yousef [3 ,4 ]
Afrashteh, Sima [5 ,6 ]
Hosamirudsari, Hadiseh [7 ]
机构
[1] Baqiyatallah Univ Med Sci, Life Style Inst, Hlth Res Ctr, Tehran, Iran
[2] Baqiyatallah Univ Med Sci, Sch Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[3] Iran Univ Med Sci, Pars Adv & Minimally Invas Med Manners Res Ctr, Pars Hosp, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[5] Bushehr Univ Med Sci, Dept Publ Hlth, Fac Hlth, Bushehr, Iran
[6] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran
[7] Univ Tehran Med Sci, Baharloo Hosp, Dept Infect Dis, Tehran, Iran
关键词
Coronavirus disease 2019; SARS-CoV-2; COVID-19; Mortality; Comorbidities; RESPIRATORY SYNDROME; RISK; INFECTION;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The current study aimed to identify effective factors on the death among COVID-19 patients. Methods: All articles published in the period Jan 1, 2020, to Mar 23, 2020, written in English and reporting factors associated with COVID-19 mortality were reviewed. The random-effects model with 95% CI was used to calculate the pooled Odds Ratio (OR) and Hazard Ratio (HR). Data were analyzed using Stata ver.11.0. Results: The older age OR: 1.21(1.10-1.33) and male gender OR: 1.41(1.04-1.89) were most prone to death due to COVID-19. The Comorbidity with some chronic diseases such as Diabetes type2 OR: 2.42(1.06-5.52), Hypertension OR: 2.54(1.21-5.32), Kidney disorder OR: 2.61(1.22-5.60), Respiratory disorder 3.09 (1.39-6.88) and Heart diseases OR: 4.37 (1.13-16.90) can increase the risk of COVID19 mortality. Conclusion: Infection with COVID-19 is associated with substantial mortality mainly in older patients with comorbidities. We found the significant effect of age, gender and comorbidities such as Diabetes Mellitus, Hypertension, Kidney disorders and Heart diseases on the risk of death in patients with COVID-19. The factors associated with mortality found in this research can help to recognize patients with COVID-19 who are at higher risk of a poor prognosis. Monitoring these factors can serve to give early warning for the appropriate interventions.
引用
收藏
页码:1211 / 1221
页数:11
相关论文
共 51 条
  • [1] Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review
    Adhikari, Sasmita Poudel
    Meng, Sha
    Wu, Yu-Ju
    Mao, Yu-Ping
    Ye, Rui-Xue
    Wang, Qing-Zhi
    Sun, Chang
    Sylvia, Sean
    Rozelle, Scott
    Raat, Hein
    Zhou, Huan
    [J]. INFECTIOUS DISEASES OF POVERTY, 2020, 9 (01)
  • [2] Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease
    Agrawal, Anurodh Shankar
    Garron, Tania
    Tao, Xinrong
    Peng, Bi-Hung
    Wakamiya, Maki
    Chan, Teh-Sheng
    Couch, Robert B.
    Tseng, Chien-Te K.
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (07) : 3659 - 3670
  • [3] Alimohamadi Yousef, 2020, J Prev Med Public Health, V53, P151, DOI 10.3961/jpmph.20.076
  • [4] Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection
    Allard, Robert
    Leclerc, Pascale
    Tremblay, Claude
    Tannenbaum, Terry-Nan
    [J]. DIABETES CARE, 2010, 33 (07) : 1491 - 1493
  • [5] Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014
    Alraddadi, Basem M.
    Watson, John T.
    Almarashi, Abdulatif
    Abedi, Glen R.
    Turkistani, Amal
    Sadran, Musallam
    Housa, Abeer
    Almazroa, Mohammad A.
    Alraihan, Naif
    Banjar, Ayman
    Albalawi, Eman
    Alhindi, Hanan
    Choudhry, Abdul Jamil
    Meiman, Jonathan G.
    Paczkowski, Magdalena
    Curns, Aaron
    Mounts, Anthony
    Feikin, Daniel R.
    Marano, Nina
    Swerdlow, David L.
    Gerber, Susan I.
    Hajjeh, Rana
    Madani, Tariq A.
    [J]. EMERGING INFECTIOUS DISEASES, 2016, 22 (01) : 49 - 55
  • [6] How will country-based mitigation measures influence the course of the COVID-19 epidemic?
    Anderson, Roy M.
    Heesterbeek, Hans
    Klinkenberg, Don
    Hollingsworth, T. Deirdre
    [J]. LANCET, 2020, 395 (10228) : 931 - 934
  • [7] Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
    Badawi, Alaa
    Ryoo, Seung Gwan
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 49 : 129 - 133
  • [8] Bonilla-Aldana D., 2020, Advances in Animal and Veterinary Sciences, V8, P234, DOI 10.17582/journal.aavs/2020/8.3.234.237
  • [9] Cao Z, 2020, ESTIMATING EFFECTIVE, DOI 10.1101/2020.01.27.20018952
  • [10] Caramelo F., 2020, MEDRXIV, DOI [10.1101/2020.02.24.20027268, DOI 10.1101/2020.02.24.20027268]